• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强直性脊柱炎的简要人类病史:发病机制、诊断与治疗的范围综述

A brief human history of ankylosing spondylitis: A scoping review of pathogenesis, diagnosis, and treatment.

作者信息

Murphy Sierra N, Nguyen Brandon A, Singh Rohin, Brown Nolan J, Shahrestani Shane, Neal Matthew T, Patel Naresh P, Kalani Maziyar A

机构信息

Mayo Clinic Alix School of Medicine, Mayo Clinic, Scottsdale, Arizona.

Department of Neurosurgery, UC Irvine, Orange, California.

出版信息

Surg Neurol Int. 2022 Jul 15;13:297. doi: 10.25259/SNI_294_2022. eCollection 2022.

DOI:10.25259/SNI_294_2022
PMID:35928330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9345125/
Abstract

BACKGROUND

Ankylosing spondylitis (AS) is a chronic, progressive, inflammatory disease of the spine and SI joints. Diagnostic criteria and treatments have continued to evolve, necessitating a historical compendium of AS and its management. This paper aims to review the historical context underlying the discovery of AS, as well as the major diagnostic and therapeutic discoveries in the last two centuries.

METHODS

A scoping review of the literature pertaining to AS was performed via the Pubmed, Scopus, and Web of Science databases. Future directions of AS treatments were assessed by querying the clinicaltrials.gov website.

RESULTS

The history of AS can be traced as far back as ancient Egypt (as evidenced by the discovery of its presence in ancient Egyptian mummies) to the late 20 century, when the inherited nature of AS was linked to a genetic factor, HLA-B27. Each discovery made throughout the years led to further investigations into the pathophysiology, diagnosis, and treatment of AS. The criteria to differentiate AS from rheumatoid arthritis were first reported in 1893. Since then, diagnostic criteria for AS have undergone a series of changes before the present-day diagnostic criteria for AS were ultimately determined in 2009 by the Assessment of Spondyloarthritis International Society.

CONCLUSION

As the pathophysiology of AS is better understood, healthcare providers are able to diagnose and treat the condition more effectively. In particular, earlier diagnosis and multiple treatment options have facilitated efficient and more effective treatment.

摘要

背景

强直性脊柱炎(AS)是一种累及脊柱和骶髂关节的慢性、进行性炎症性疾病。诊断标准和治疗方法不断演变,因此有必要对AS及其管理进行历史综述。本文旨在回顾AS发现背后的历史背景,以及过去两个世纪的主要诊断和治疗发现。

方法

通过PubMed、Scopus和Web of Science数据库对与AS相关的文献进行范围综述。通过查询clinicaltrials.gov网站评估AS治疗的未来方向。

结果

AS的历史可以追溯到古埃及(古埃及木乃伊中发现AS的存在可证明),一直到20世纪后期,当时AS的遗传性质与遗传因素HLA-B27联系起来。多年来的每一项发现都促使对AS的病理生理学、诊断和治疗进行进一步研究。1893年首次报道了区分AS与类风湿关节炎的标准。从那时起,AS的诊断标准经历了一系列变化,直到2009年国际脊柱关节炎评估协会最终确定了当今AS的诊断标准。

结论

随着对AS病理生理学的更好理解,医疗保健提供者能够更有效地诊断和治疗该疾病。特别是,早期诊断和多种治疗选择促进了高效和更有效的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1316/9345125/1dcf61b38162/SNI-13-297-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1316/9345125/24575c648238/SNI-13-297-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1316/9345125/e081083f2689/SNI-13-297-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1316/9345125/1dcf61b38162/SNI-13-297-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1316/9345125/24575c648238/SNI-13-297-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1316/9345125/e081083f2689/SNI-13-297-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1316/9345125/1dcf61b38162/SNI-13-297-g003.jpg

相似文献

1
A brief human history of ankylosing spondylitis: A scoping review of pathogenesis, diagnosis, and treatment.强直性脊柱炎的简要人类病史:发病机制、诊断与治疗的范围综述
Surg Neurol Int. 2022 Jul 15;13:297. doi: 10.25259/SNI_294_2022. eCollection 2022.
2
Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.未确诊的强直性脊柱炎病例中的血清阳性视神经脊髓炎:一个神经风湿病学难题
Qatar Med J. 2022 Jul 7;2022(3):29. doi: 10.5339/qmj.2022.29. eCollection 2022.
3
Ankylosing Spondylitis and Axial Spondyloarthritis in Patients With Long-term Inflammatory Bowel Disease: Results From 20 Years of Follow-up in the IBSEN Study.长期炎症性肠病患者的强直性脊柱炎和中轴型脊柱关节炎:IBSEN 研究 20 年随访结果。
J Crohns Colitis. 2018 Jan 5;12(1):96-104. doi: 10.1093/ecco-jcc/jjx126.
4
Evaluation of the Possibility of Axial Psoriatic Arthritis Patients Meeting Classification Criteria for Axial Spondyloarthritis and Ankylosing Spondylitis.评估符合中轴型银屑病关节炎分类标准的患者是否符合中轴型脊柱关节炎和强直性脊柱炎的分类标准。
Dokl Biochem Biophys. 2024 Aug;517(1):173-181. doi: 10.1134/S160767292470087X. Epub 2024 Jun 10.
5
Ankylosing spondylitis or diffuse idiopathic skeletal hyperostosis in royal Egyptian mummies of 18th -20th Dynasties? CT and archaeology studies.18-20 王朝的埃及皇家木乃伊中存在强直性脊柱炎或弥漫性特发性骨肥厚?CT 和考古研究。
Arthritis Rheumatol. 2014 Dec;66(12):3311-6. doi: 10.1002/art.38864.
6
Profile of HLA-B27-positive enthesitis/spondylitis-related arthritis in Senegal, West Africa.塞内加尔(西非) HLA-B27 阳性附着点炎/脊柱炎相关关节炎患者的特征。
Pediatr Rheumatol Online J. 2024 Feb 29;22(1):31. doi: 10.1186/s12969-024-00969-1.
7
Registry of the clinical characteristics of spondyloarthritis in a cohort of Egyptian population.强直性脊柱炎临床特征的队列研究在埃及人群中的应用。
Rheumatol Int. 2012 Sep;32(9):2837-42. doi: 10.1007/s00296-011-2068-7. Epub 2011 Aug 31.
8
The history of ankylosing spondylitis/axial spondyloarthritis - what is the driving force of new knowledge?强直性脊柱炎/中轴型脊柱关节炎的历史——新知识的驱动力是什么?
Semin Arthritis Rheum. 2025 Apr;71:152611. doi: 10.1016/j.semarthrit.2024.152611. Epub 2024 Dec 22.
9
Diagnosis and Treatment of Ankylosing Spondylitis.强直性脊柱炎的诊断与治疗
Cureus. 2024 Jan 19;16(1):e52559. doi: 10.7759/cureus.52559. eCollection 2024 Jan.
10
A review of the pathogenesis of ankylosing spondylitis.强直性脊柱炎发病机制综述。
Neurosurg Focus. 2008;24(1):E2. doi: 10.3171/FOC/2008/24/1/E2.

引用本文的文献

1
Role of High Serum Tenascin C Levels as Potential Biomarker of Persistent Inflammation in Patients with Ankylosing Spondylitis Despite Treatment with cs-DMARDS or Anti-TNF Agents.高血清腱生蛋白C水平作为强直性脊柱炎患者尽管接受传统合成改善病情抗风湿药(cs-DMARDS)或抗TNF药物治疗后仍存在持续炎症的潜在生物标志物的作用。
Diagnostics (Basel). 2025 Jun 7;15(12):1457. doi: 10.3390/diagnostics15121457.
2
[Not Available].[无可用内容]。
CMAJ. 2025 Mar 30;197(12):E342-E343. doi: 10.1503/cmaj.241337-f.
3
A chalk-stick fracture in an 81-year-old man with ankylosing spondylitis.

本文引用的文献

1
The Effects of Tele-Yoga in Ankylosing Spondylitis Patients: A Randomized Controlled Trial.远程瑜伽对强直性脊柱炎患者的影响:一项随机对照试验。
J Integr Complement Med. 2023 Nov;29(11):727-737. doi: 10.1089/jicm.2023.0022. Epub 2023 May 31.
2
Racial Differences in Prevalence and Treatment for Psoriatic Arthritis and Ankylosing Spondylitis by Insurance Coverage in the USA.美国银屑病关节炎和强直性脊柱炎患病率及治疗的种族差异与保险覆盖情况
Rheumatol Ther. 2021 Dec;8(4):1725-1739. doi: 10.1007/s40744-021-00370-4. Epub 2021 Sep 25.
3
Incidence of Ankylosing Spondylitis Among Male and Female United States Army Personnel.
一名81岁强直性脊柱炎男性患者的粉笔样骨折。
CMAJ. 2025 Feb 2;197(4):E97. doi: 10.1503/cmaj.241337.
4
The role of miRNAs as biomarkers in heterotopic ossification.微小RNA作为生物标志物在异位骨化中的作用。
EFORT Open Rev. 2024 Dec 2;9(12):1120-1133. doi: 10.1530/EOR-22-0100.
5
Prevalence of temporomandibular joint dysfunction in patients with ankylosing spondylitis and comparison of the findings with healthy controls.强直性脊柱炎患者颞下颌关节功能障碍的患病率及其与健康对照者的结果比较。
Rev Assoc Med Bras (1992). 2024 Sep 30;70(10):e20240807. doi: 10.1590/1806-9282.20240807. eCollection 2024.
6
Lumbar pedicle subtraction osteotomy: techniques and outcomes.腰椎椎体截骨术:技术与结果
N Am Spine Soc J. 2024 Jul 6;19:100516. doi: 10.1016/j.xnsj.2024.100516. eCollection 2024 Sep.
7
Rheumatoid Arthritis and Its Implications on Inflammatory Bowel Disease.类风湿关节炎及其对炎症性肠病的影响。
J Clin Med Res. 2024 Apr;16(4):170-173. doi: 10.14740/jocmr5121. Epub 2024 Apr 30.
美国陆军男性和女性强直性脊柱炎发病率。
Arthritis Care Res (Hoboken). 2023 Feb;75(2):332-339. doi: 10.1002/acr.24774. Epub 2022 Oct 29.
4
GlutenSpA trial: protocol for a randomised double-blind placebo-controlled trial of the impact of a gluten-free diet on quality of life in patients with axial spondyloarthritis.谷胶素研究:一项随机双盲安慰剂对照试验方案,旨在研究无谷胶饮食对强直性脊柱炎患者生活质量的影响。
BMJ Open. 2020 Nov 20;10(11):e038715. doi: 10.1136/bmjopen-2020-038715.
5
Physical therapy in axial spondyloarthritis: guidelines, evidence and clinical practice.轴性脊柱关节炎的物理治疗:指南、证据和临床实践。
Curr Opin Rheumatol. 2020 Jul;32(4):365-370. doi: 10.1097/BOR.0000000000000714.
6
State of the Art Management of Aortic Valve Disease in Ankylosing Spondylitis.强直性脊柱炎主动脉瓣病变的治疗现状。
Curr Rheumatol Rep. 2020 May 14;22(6):23. doi: 10.1007/s11926-020-00898-4.
7
Advances in nanomedicine for the treatment of ankylosing spondylitis.纳米医学在治疗强直性脊柱炎方面的进展。
Int J Nanomedicine. 2019 Oct 29;14:8521-8542. doi: 10.2147/IJN.S216199. eCollection 2019.
8
Ankylosing spondylitis: etiology, pathogenesis, and treatments.强直性脊柱炎:病因、发病机制及治疗方法
Bone Res. 2019 Aug 5;7:22. doi: 10.1038/s41413-019-0057-8. eCollection 2019.
9
Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity?轴向性脊柱关节炎中肠易激综合征症状比健康对照组更常见:这是一种被忽视的合并症吗?
Ann Rheum Dis. 2020 Jan;79(1):159-161. doi: 10.1136/annrheumdis-2019-216134. Epub 2019 Oct 4.
10
Trends in diagnostic prevalence and treatment patterns of male and female ankylosing spondylitis patients in the United States, 2006-2016.2006 - 2016年美国男性和女性强直性脊柱炎患者的诊断患病率及治疗模式趋势
BMC Rheumatol. 2019 Sep 23;3:39. doi: 10.1186/s41927-019-0086-3. eCollection 2019.